| (Eli Lilly) J6C-OX-JKFA / OMNIRAY | A Phase 1a/b Multicenter, Open-Label Trial to Evaluate Safety, Tolerability, and Dosimetry of LY4257496, a GRPR-Targeted Radioligand Therapy, in Adults With GRPR-Positive Advanced Solid Tumors (OMNIRAY) | Dr Sebastien Hotte | Open to recruitment | NCT07114601 |
| (GSK) GSK 224035 | A phase 1/2 open-label, multicenter study of oral GSK5460025 alone or in combination with other anti-cancer agents in adult participants with Mismatch Repair-deficient (dMMR) or Microsatellite Instability-High (MSI-H) solid tumors. | Dr Courtney Coschi | Suspended/On hold | NCT07213609 |
| (GSK) 223054 / EMBOLD PanTumor-101 | A Phase 1 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Clinical Activity of GSK5764227 in Participants with Advanced Solid Tumours | Dr Courtney Coschi | Open to recruitment | NCT06551142 |
Find a Trial
Contact Us